Home/The Journal of Medical Laboratory Science & Technology of South Africa/Article Record
Peer-Reviewed Article December 31, 2018

Immunotherapy for Treatment of Resistant Cancer

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: The Journal of Medical Laboratory Science & Technology of South Africa
Publisher: AOSIS • South Africa • 2664-2549 • 2664-2832

Abstract

Background: Cancer is the leading cause of mortality in developed countries and second cause of disease in developing countries. The aetiology of cancer resistance is prolonged exposure to carcinogenic agents and adaptation of cancer associated lifestyles, such as: smoking, diet, alcohol, sun exposure, and environmental to name just a few.   Objective: This literature review aimed to highlight different immunotherapeutic approaches in the treatment and management of resistant cancer.   Method: A literature review of pertinent literature was conducted to ascertain the effectiveness of immunotherapy in resistant cancer. Google Scholar, PubMed and research gate were used to obtained related journal articles.   Results: Immunotherapy has proven to be the best therapeutic approach to be applied in the treatment of resistant cancer as it induces the immune system to produce specific antibodies to cancer surface antigens.   Conclusion: Immunotherapy is the best therapeutic approach to be employed in treatment and management of resistant cancer.

Download Full Text PDFView at PublisherCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

3
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.